Deepak Nath vs Kevin Lobo

Deepak Nath

CEO of Smith & Nephew

BIO: Deepak Nath joined Smith+Nephew in April 2022 and has a track record of driving growth at major healthcare companies through delivering a significant improvement in execution and building a strong results-focused culture. He began his career as a scientist in computational physics at Lawrence Livermore National Laboratory and holds a BSc and MSc in Mechanical Engineering and a PhD in Theoretical Mechanics from the University of California, Berkeley. Prior to joining Siemens Healthineers, he held roles at both Amgen and McKinsey and spent 10 years at Abbott Laboratories, Inc. culminating in his appointment as President of Abbott Vascular. At Siemens Healthineers (2018–2022) he was President of the Diagnostics business responsible for $6 billion of revenue and 15,000 employees.

Kevin Lobo

CEO of Stryker

BIO: Kevin A. Lobo has been CEO of Stryker since October 1, 2012, and also assumed the role of Chairman of the Board on July 22, 2014. Mr. Lobo joined Stryker in 2011 and had previously been Group President of Orthopaedics. Mr. Lobo is the chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors and serves on the Board of Directors for Parker Hannifin Corporation, the global leader in motion and control technologies. He is also a member of the Business Roundtable and Business Council and serves on some community boards. Mr. Lobo has a broad business career that includes executive positions in general management and finance. After holding finance positions with KPMG, Unilever and Kraft Canada he spent eight years with Rhone-Poulenc, including roles based in Europeas Corporate Controller of Rhodia, the chemical spin-out, and General Manager of Specialty Phosphates EMEA. He then spent eight years at Johnson & Johnson, including President J&J Medical Canada and President of Ethicon Endo Surgery.